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Axonal degeneration is a characteristic feature of
neurodegenerative disease and nerve injury. Here,
we characterize axonal degeneration in Caenorhab-
ditis elegans neurons following laser-induced axot-
omy. We show that this process proceeds indepen-
dently of the WLDS and Nmnat pathway and
requires the axonal clearance machinery that in-
cludes the conserved transmembrane receptor
CED-1/Draper, the adaptor protein CED-6, the
guanine nucleotide exchange factor complex Crk/
Mbc/dCed-12 (CED-2/CED-5/CED-12), and the
small GTPase Rac1 (CED-10). We demonstrate
that CED-1 and CED-6 function non-cell autono-
mously in the surrounding hypodermis, which we
show acts as the engulfing tissue for the severed
axon. Moreover, we establish a function in this pro-
cess for CED-7, an ATP-binding cassette (ABC)
transporter, and NRF-5, a lipid-binding protein,
both associated with release of lipid-vesicles during
apoptotic cell clearance. Thus, our results reveal the
existence of a WLDS/Nmnat-independent axonal
degeneration pathway, conservation of the axonal
clearance machinery, and a function for CED-7
and NRF-5 in this process.INTRODUCTION
The axon is a neuron’s longest neurite, requiring its structure to
be actively maintained by support from the cell body through
axonal transport, as well as from associated glial cells (Cole-
man, 2011). Following trauma or transection, the axon un-
dergoes a stereotypical degenerative process termed Wallerian
degeneration. This process consists of a latent phase followed
by beading, thinning, fragmentation, and finally clearance ofCell Raxonal debris by macrophages (Martini et al., 2008; Waller,
1850). Wallerian degeneration has been described across
many vertebrate species as well as in Drosophila (MacDonald
et al., 2006; Martin et al., 2010). The discovery of the Wallerian
degeneration slow (WldS) mutation in mice, which drastically
delays the onset of degeneration (Lunn et al., 1989), suggested
that degeneration is the result of an active molecular pathway
that can be manipulated. Expression of the murine WldS gene
is able to robustly and potently delay axonal degeneration in
every species tested, including rat, zebrafish, and Drosophila
(Adalbert et al., 2005; Avery et al., 2009; Beirowski et al.,
2008; Martin et al., 2010). WldS encodes a chimeric protein
consisting of the first 70 N-terminal amino acids from the ubiq-
uitin fusion degradation protein 2a (UFD2a), a unique 18-amino-
acid linker region, and the full in-frame sequence of nicotin-
amide mononucleotide adenylyltransferase 1 (Nmnat1) (Con-
forti et al., 2000). Further studies have shown that it is the
Nmnat portion that confers neuroprotection in WldS animals,
and that the endogenous Nmnat2 protein in mice and its
Drosophila homolog dNmnat are crucial axon survival factors
(Fang et al., 2012; Gilley and Coleman, 2010). Upstream of
dNmnat, the highly conserved E3 ubiquitin ligase Highwire
(RPM-1 in C. elegans) promotes axonal degeneration while
also acting through a parallel pathway involving the dual leucine
kinase Wallenda (DLK-1 in C. elegans) (Xiong et al., 2012). In
addition to its function in axonal degeneration in Drosophila,
Wallenda/DLK-1 is also implicated in Wallerian degeneration
in mice (Ghosh et al., 2011; Miller et al., 2009). Furthermore,
a forward genetic screen in severed olfactory receptor neurons
of Drosophila identified dSarm (TIR-1 in C. elegans) as an
extremely potent promoter of axonal degeneration, an effect
that is conserved in mice (Osterloh et al., 2012). Axonal degen-
eration ultimately ends with clearance of the axonal debris, and
glial cells have been shown to play a key role in this process in
both vertebrates and Drosophila (Doherty et al., 2009; Martini
et al., 2008; Stoll et al., 1989). Importantly, despite axonal
degeneration being distinct from apoptosis (Finn et al., 2000;
Osterloh et al., 2012; Whitmore et al., 2003), the clearance of
axonal debris shares molecular elements with the clearanceeports 14, 1673–1683, February 23, 2016 ª2016 The Authors 1673
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Figure 1. Characterization of Axonal Degeneration in C. elegans Neurons following Laser-Induced Axotomy
(A) Representative images and schematics of progressive stages of axonal degeneration after axotomy in PLM neurons in different L4 animals expressing the
zdIs5(Pmec-4::GFP) transgene. Arrowheads indicate location of axotomy, asterisks indicate the end of the regrowing axon, and an arrow points to a distal
fragment. The PVM neuron, which also expresses GFP, is represented in gray. Scale bar, 50 mm. Degeneration of the distal fragment classified as the Axonal
Integrity Score with a value of 1 (completely cleared) to 5 (intact). The panel on the right is a schematic representation of these phenotypes.
(legend continued on next page)
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of apoptotic cells. In particular, the apoptotic molecules Draper
and dCed-6 (CED-1 and CED-6 in C. elegans) are required for
the activation and recruitment of glial cells to degenerating
Drosophila axons (MacDonald et al., 2006; Ziegenfuss et al.,
2012). Furthermore, the guanine nucleotide exchange factor
complex Crk/Mbc/dCed-12 and the small GTPase Rac1
(CED-2/CED-5/CED-12 and CED-10 in C. elegans) have been
shown to function downstream of Draper and dCed-6 to pro-
mote the clearance of axonal debris (Ziegenfuss et al., 2012).
However, many details of this clearance process, as well as
possible alternative pathways and the molecules that regulate
this event, remain unknown.
Although several studies have examined axonal degeneration
in C. elegans in the context of neurodegenerative disease
models and neuronal dysfunction (Calixto et al., 2012; Nagara-
jan et al., 2014; Neumann and Hilliard, 2014; Neumann et al.,
2011), no Wallerian degeneration (i.e., severed axon) paradigm
has been investigated. Here, we provide a detailed character-
ization of axonal degeneration in C. elegans neurons following
laser-induced axotomy and show that it proceeds indepen-
dently from the WldS/Nmnat pathway. We identify a conserved
function for the axonal clearance molecules CED-1 and CED-6,
and the intracellular pathway that includes CED-2, CED-5,
CED-12, and CED-10. Importantly, we also reveal a function
in this process for the ATP-binding cassette (ABC) transporter
CED-7 and the lipid-binding protein NRF-5 and identify the hy-
podermis as an engulfing tissue for the severed PLM axon
fragments.
RESULTS
Characterization of Axonal Degeneration in C. elegans
The C. elegans mechanosensory neurons have been exten-
sively studied as a model for both neurodegeneration and
regeneration, and are among the best-characterized neurons
in the nematode nervous system (Chalfie et al., 1985; Huang
and Chalfie, 1994; Miyasaka et al., 2005; Neumann et al.,
2011, 2015; Zhang et al., 2008). We selected the posterior
mechanosensory neurons (PLM left and right) in which to char-
acterize axonal degeneration and visualized these neurons with
the zdIs5(Pmec-4::GFP) transgene (Figure 1A). We then used
laser-induced axotomy to selectively transect single PLM
axons, allowing us to investigate the subsequent degeneration
of the separated distal fragment. In wild-type animals, we found
that the axon degenerated in a stereotypical manner, with sim-
ilarities to Wallerian degeneration in other species, including
thinning, beading, fragmentation, and clearance of the sepa-
rated distal fragment (Figure 1A). However, unlike in other spe-
cies, we did not observe a delay between the fragmentation and
clearance phases of the degenerating axon, with these two pro-
cesses apparently occurring simultaneously in different regions(B–G) Representative EM images of the degenerating PLM axon on the axotomize
The axon is intact upstream of the injury site (D), whereas in regions distal to the i
(see also Figures S1E and S1F). On the contrary, on the unoperated contralatera
(H and I) Axonal degeneration at multiple time points post-axotomy of the PLM neu
of data points that fall into that category; n value indicated on top of each bubbl
(J) Pie graph representing the complete clearance (score of 1) after 24 hr in PLM
Cell Rof the axon. To determine whether the axonal degeneration
phenotypes observed were indeed due to changes in axonal
morphology, and not specific to the cytoplasmic GFP signal,
we first analyzed animals expressing a membrane-bound fluo-
rophore (Pmec-4::MYR::mCherry) together with cytoplasmic
GFP. The degenerative phenotypes observed using the two
different fluorophores were nearly identical (Figure S1A). Sec-
ond, we obtained electron microscopy (EM) serial transverse
sections of two unilaterally axotomized L4 (fourth larval stage)
animals. We found that the thinning observed with epifluores-
cence corresponded to a decreased diameter of the axon
compared to that on the contralateral uninjured side, with a
highly reduced number of the mechanosensory neuron-specific
large diameter microtubules (Figures 1B–1G, S1E, and S1F).
Furthermore, we found that the PLM axon on the injured side
was discontinuous, matching the observation of axonal breaks
made with epifluorescence (Figures 1B–1D, S1E, and S1F).
Based on these classical morphological indicators of degener-
ation, we developed a five-point scale (Axonal Integrity Score)
to score the degeneration of the distal fragment (Figure 1A),
with 1 indicating complete clearance, and 5 indicating no signs
of degeneration.
It has previously been suggested that axonal degeneration
in C. elegans is developmentally dependent (Wu et al.,
2007). To investigate this further, we compared the degenera-
tion in L1 (first larval stage) and L4 animals at different time
points after axotomy. In the majority of L1 animals, we found
that the distal fragment was completely cleared by 24 hr
post-axotomy (Figures 1H and 1J). This was in stark contrast
to the L4 animals, in which the distal fragment was still
present—although visibly degenerated—as late as 10 days
post-axotomy (Figures 1I and 1J). We also performed axoto-
mies at different time points after hatching and scored the
degeneration 24 hr later, revealing that the rate of axonal
degeneration was maximal within the first 10 hr after hatching,
approximately corresponding to the duration of the L1 stage
(Figure S1B).
To determine whether the progression of degeneration and
developmental stage-dependent differences were a general
feature of the nervous system, we also performed axoto-
mies on the GABAergic DD motor neurons (visualized with
the ynIs37(Pflp-13::GFP) transgene). Axonal degeneration pro-
ceeded rapidly in L1 animals, with complete clearance observed
in the majority of animals 24 hr post-axotomy (Figures 1J and
S1C). However, we again observed a far more gradual rate
of degeneration in L4 animals, with complete clearance
not observed until as late as 72 hr post-axotomy (Figures 1J
and S1D). These results suggest that developmental stage-
dependent differences in degeneration could be a general char-
acteristic of C. elegans neurons, providing a platform to investi-
gate axonal degeneration in this species.d side (B–D) compared to the intact PLM axon on the non-operated side (E–G).
njury site it becomes severely reduced in diameter (C) or completely absent (B)
l side, PLM is intact along its entire length (E–G).
rons at L1 (H) or L4 (I) stages. The area of each circle represents the proportion
e graph. Each animal was imaged at only one time point.
and DD neurons in L1 and L4 animals.
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Figure 2. Overexpression of WldS or the Endogenous Nmnat Genes, nmat-1 and 2, Has No Protective Effect against Axonal Degeneration
after Laser-Induced Axotomy in PLM Neurons
(A)Axonal degenerationof representative transgenic strainsexpressingPmec-4::WldSat low (5ng/ml),medium (10ng/ml), or high (20ng/ml) concentrations, 16hrpost-
axotomy at the L1 stage.
(B) Axonal degeneration of the PLM neuron in representative Pmec-4::nmat-1 and Pmec-4::nmat-2 lines at low (5 ng/ml) and high (20 ng/ml) concentrations 16 hr
post-axotomy at the L1 stage. The high concentration of Pmec-4::nmat-2 induced an increase in degeneration.
(C) Quantification of PLM axonal degeneration at the L1 stage in rpm-1(ju41), dlk-1(ju476), tir-1(tm3036), or tir-1(ok1052) animals compared to wild-type (WT)
animals 16 hr post-axotomy. The area of each circle represents the proportion of data points that fall into that category; n value indicated on top of each bubble
graph. *p < 0.05 as determined by either a Mann-Whitney test or a Kruskal-Wallis and Dunn’s test.WLDS and Nmnats Do Not Delay Laser-Induced Axonal
Degeneration in C. elegans
In both vertebrates and Drosophila, Wallerian degeneration has
been shown to proceed through a highly conserved pathway
that can be characterized by the protective effect of the WldS
gene. To determine whether this pathway is conserved in
C. elegans, we generated transgenic strains that expressed
the murine WldS gene in the six mechanosensory neurons. Sur-
prisingly, and contrary to what has been observed in other or-
ganisms, we did not find any delay in axonal degeneration in
WldS strains at either the L1 (Figures 2A and S2A) or L4 stage
(Figure S2B). Moreover, we found that this lack of protection
was not a function of neuronal class, as WLDS did not delay
axonal degeneration in either the AVM mechanosensory neuron
(Figure S2C) or the DD motor neurons of L4 animals (Fig-
ure S2D). However, WLDS did maintain function, as it protected
against neurodegeneration caused by a dominant mutation in
the degenerin channel MEC-4(d), similar to the overexpression
of the C. elegans Nmnat2 (Calixto et al., 2012) (Figure S2E).
Moreover, unlike in other species (MacDonald et al., 2006; Sa-1676 Cell Reports 14, 1673–1683, February 23, 2016 ª2016 The Authsaki et al., 2009), overexpression of the C. elegans Nmnat
genes (nmat-1 or nmat-2) in the six mechanosensory neurons
could not delay axonal degeneration in L1 or L4 animals (Fig-
ures 2B and S2F–S2H). These results reveal that neither over-
expression of WLDS nor the presence of endogenous Nmnat
proteins is able to delay laser-induced axonal degeneration in
C. elegans.
In the past decade, three genes have been identified as pro-
moters of the Wallerian degeneration pathway in Drosophila
and/or mice: Sarm1 (Osterloh et al., 2012), Wallenda/Dlk1
(Ghosh et al., 2011; Miller et al., 2009; Xiong et al., 2010), and
the E3 ubiquitin ligase Highwire (Xiong et al., 2012). We found
that mutations in the C. elegans homologs of these genes,
tir-1, dlk-1, and rpm-1, had no protective effect on axonal degen-
eration of PLM neurons (Figures 2C and S3A). Taken together,
these results point to a possible divergence in C. elegans, such
that the functions of key molecules identified in other species
are not conserved in the context of axonal degeneration
following axotomy, suggesting the existence of redundant path-
ways and/or other still unidentified molecules.ors
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Figure 3. Conserved Components of the
Apoptotic Cell Clearance Machinery Regu-
late the Axonal Degeneration Phenotype of
the PLM Neurons
(A) Mutations in the apoptotic cell clearance genes
ced-6(n1813), ced-1(e1735), ced-12(bz187), ced-
10(n3246), ced-5(n1812), ced-2(e1752), ced-
7(n2094), ced-7(n2690), and nrf-5(sa513) delay
axonal degeneration in L1 animals.
(B) Mutations in the other apoptotic-related genes
ced-3(n2452), ced-4(n1162), ttr-52(sm211), psr-
1(ok714), ina-1(gn144), tat-1(tm3117), and scrm-
1(tm805) have no effect on axonal degeneration
following axotomy in L1 animals. The area of each
circle represents the proportion of data points that
fall into that category; n value indicated on top of
each bubble graph. *p < 0.05, **p < 0.005, ***p <
0.0005 as determined by a Kruskal-Wallis and
Dunn’s or a Mann-Whitney test.A Role for CED-7 and NRF-5 in Regulating Axonal
Degeneration/Clearance
As expected from studies in different species, we found no effect
on axonal degeneration in mutants of genes of the canonical
apoptosis pathway, ced-3 and ced-4 (Figures 3B and S3A), indi-
cating that the axonal degeneration process in C. elegans, as in
vertebrates, is not regulated by caspase function (Finn et al.,
2000). However, in several species, clearance of severed axonal
fragments by glial cells has been shown to use some of the
same molecular components necessary for the engulfment
of apoptotic cells. For example, the apoptotic engulfment
genes Draper and dCed-6 are needed for axonal clearance in
Drosophila and mice (Awasaki et al., 2006; MacDonald et al.,
2006). Similarly, Crk/Mbc/dCed-12 and Rac1 have also been
shown to function in this process (Ziegenfuss et al., 2012). To
determine whether this molecular machinery is also employed
in C. elegans, we examined animals carrying mutations in the
orthologous genes. We found that animals mutant for ced-6,
ced-1, ced-12, or ced-10 all displayed a significantly decreased
axonal degeneration phenotype following axotomy of PLM at the
L1 stage (Figure 3A). As CED-12 acts in amolecular complex that
includes CED-5 (mammalian Dock180) and CED-2 (mammalian
CrkII) (Gumienny et al., 2001), we also tested animals carrying
mutations in each of these genes and found that each mutant
displayed a defective degenerative phenotype compared to
wild-type animals (Figure 3A). In other species, all of these
apoptotic molecules function in glial cells, which are responsible
for the clearance of the damaged axon, and thus their role is non-
cell autonomous with respect to the damaged neuron. However,
the cells that can engulf the damaged axonal fragments in
C. elegans have not previously been identified. At the L1 stage,
PLM is tightly associated with the hypodermis, and later be-Cell Reports 14, 1673–1683, Fcomes embedded in this tissue (Chalfie
and Sulston, 1981). We therefore hypoth-
esized that the hypodermis might be
responsible for engulfment of the distal
fragment after axotomy. To test this, we
generated transgenic ced-6 mutant ani-
mals in which wild-type CED-6 wastagged with mRFP and selectively expressed in the hypodermis
using the dpy-7 promoter (Pdpy-7::mRFP::CED-6) (Gilleard
et al., 1997). Strikingly, we found a strong rescue of the PLM
defect (Figures 4A and 4B), indicating that the hypodermis is a
key tissue in this process. In agreement with this conclusion,
cell-autonomous expression of CED-6 (Pmec-4::mRFP::CED-
6) failed to rescue the defect (Figure 4A). Similarly, expression
of wild-type CED-1 tagged with mRFP in the hypodermis
(Pdpy-7::mRFP::CED-1) was able to strongly rescue the defects
of ced-1 mutant animals (Figures 4C and 4D), confirming that
CED-1 and CED-6 both act within the engulfing cells. These re-
sults are consistent with our EM imaging data of L4 animals (Fig-
ures 1B–1D, S1E, and S1F), where we found evidence of mem-
brane whorls in the hypodermis in areas where the PLM axon
was absent; these morphological changes in the hypodermis
are strongly suggestive of a role of this tissue in the engulfment
and clearance of the axon. In summary, we find that the molec-
ular elements responsible for the clearance of severed axon frag-
ments are conserved across species and reveal that the hypo-
dermal cells play a role in this process in C. elegans.
During apoptosis, the CED-1 receptor present on an engulfing
cell recognizes apoptotic cells through the exposure of phos-
phatidylserine (PS) on their membranes (Zhou et al., 2001).
This process is facilitated by the ABC transporter CED-7, which
promotes the generation of extracellular PS-containing vesicles
(Mapes et al., 2012). To determine whether CED-7 contributes to
the axonal degeneration phenotype, we analyzed the PLM axon
in ced-7mutants after axotomy. Interestingly, these animals pre-
sented a striking defect at the L1 stage, resembling that
observed for the other apoptotic engulfment genes analyzed
(Figure 3A). Given the possible role of PS in this process, we
then tested whether similar phenotypes were also present inebruary 23, 2016 ª2016 The Authors 1677
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Figure 4. CED-1 and CED-6 Function in the Hypodermis
(A) Cell-specific expression of Pmec-4::mRFP::
CED-6 indicates that themolecule does not act cell autonomously in PLM neuron, whereas expression ofPdpy-7::mRFP::CED-6 in the hypodermis is sufficient to
rescue the diminished degeneration and clearance in ced-6(n1813)mutants. This strain is representative for three independent rescue strains (data not shown).
(B) Localization of Pdpy-7::mRFP::CED-6 in the hypodermis in an animal at the L1 stage, 16 hr after axotomy.
(C) Cell-specific expression of Pdpy-7::CED-1::
mRFP is sufficient to rescue the diminished degeneration and clearance in ced-1(e1735)mutants. This strain is representative of three independent rescue strains
(data not shown).
(D) Localization of Pdpy-7::CED-1::mRFP in the hypodermis and seam cells in an animal at the L1 stage, 16 hr after axotomy. The area of each circle in (A) and (C)
represents the proportion of data points that fall into that category; n value indicated on top of each bubble graph. *p < 0.05, **p < 0.005, as determined by a
Kruskal-Wallis and Dunn’s or a Mann-Whitney test. Scale bars, 20 mm. Arrowheads indicate the location of axotomy, brackets indicate regrowth, and asterisks
mark the hypodermal and seam cell nuclei.
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animals carrying mutations in nrf-5, which encodes a lipid-bind-
ing protein that functionswith CED-7 tomediate PS transfer from
apoptotic cells to phagocytes (Zhang et al., 2012). We found a
significant defect in the PLM axonal degeneration phenotype
following axotomy in nrf-5 mutant animals (Figure 3A). On the
contrary, we observed no such effect in animals lacking TTR-
52 (a secreted transthyretin-like protein that acts as a bridging
molecule between CED-1 and PS [Wang et al., 2010]), PSR-1
or INA-1 (both PS membrane receptors [Hsu and Wu, 2010;
Wang et al., 2003]) (Figure 3B), suggesting that these molecules
either are not involved or have redundant roles in this process.
Axonal degeneration/clearance also appeared normal in mu-
tants of genes encoding for known PS-regulating molecules
such as TAT-1 (an ATPase required for regulating PS asymmetry
[Darland-Ransom et al., 2008]) and SCRM-1 (a phospholipid
scramblase required for PS exposure [Wang et al., 2007]) (Fig-
ure 3B). Furthermore, using a mRFP-tagged version of Annexin
V (sAnxV::mRFP) that binds PS (Mapes et al., 2012), we could
not detect PS on the axonal fragment in L1, and its overexpres-
sion did not affect the axonal degeneration phenotype (Fig-
ure S3C), as would be expected if PS exposure functioned in
this process. Our data therefore suggest that PS might have,
at most, only a minor role in axonal degeneration/clearance, or
that CED-7 and NRF-5 could facilitate the transport of other
lipids or molecules.
Axonal Degeneration/Clearance Is Modulated by CED-7
and Mitochondria
The role of CED-7 appears to change with developmental stage,
as compared with wild-type animals ced-7 mutants exhibited a
delayed degenerative phenotype at the L1 stage (Figure 3A)
but an increased rate at the L4 stage (Figure S3B). This develop-
mental switch may be explained by a time-dependent role of
CED-7 in regulating the secretion of lipids or other molecules.
For example, in the context of apoptotic clearance, CED-7 not
only promotes the generation of PS-containing extracellular ves-
icles, but is also required to remove externalized PS from unen-
gulfed apoptotic cells over time (Mapes et al., 2012). This dual
function of CED-7, with early production of lipid-containing ves-
icles promoting clearance and later removal of lipids from the de-
generating axon preventing clearance, could explain its different
effects at the L1 and L4 stages.
We also tested a number of other factors that potentially alter
the axonal degeneration phenotype. Presynaptic loci are pre-
sent on the PLM axon at the L4 stage but not at the L1 stage,
as revealed by the absence of the synaptic vesicle-associated
small guanosine triphosphatase RAB-3 on the PLM synaptic
branch in L1 animals (Figures S4A and S4B). To investigate
whether the presence of synapses stabilized the axon, we sev-
ered both the PLM synaptic branch and the main PLM axon in
L4 animals; however, we found no difference in the degenera-
tive phenotype between axons deprived of their synaptic
branch and those with an intact branch (Figure S4C). The
PLM axon is positioned adjacent to both the hypodermis and
the muscle during the L1 stage, becoming separated from
the muscle by the embedding hypodermis in L4 animals (Emt-
age et al., 2004). To test for a possible positional effect of the
axon, we carried out axotomies in L4 mec-1 mutant animalsCell Rin which the hypodermis fails to establish this separation (Emt-
age et al., 2004). Our results showed no significant difference in
the degenerative phenotype between wild-type and mec-1
mutant animals (Figure S4D), indicating that the location of
the PLM axon with respect to the surrounding tissues is not
responsible for the differences in the degeneration between
L1 and L4 stage animals.
A recent study has shown that the presence of mitochondria in
C. elegans axons protects from degeneration following axotomy
(Rawson et al., 2014). To ascertain whether mitochondria
might similarly modulate the rate of degeneration in PLM,
we performed axotomies in animals carrying a mutation in the
ric-7 gene that disrupts mitochondrial transport, resulting in the
accumulation of mitochondria in neuronal cell bodies and a
near complete absence in neurites (Rawson et al., 2014) (Figures
5A and S5). We found that L4 ric-7 mutant animals displayed a
very rapid axonal degenerative phenotype, withmore than a third
of axons completely cleared 24 hr post-axotomy (Figure 5B), a
rate of degeneration comparable to that of L1 wild-type animals.
To determine whether this effect was specifically due to the
lack of mitochondria in the PLM axon, we rescued the normal
localization of mitochondria by tethering them to a kinesin
protein (Pmec-4::UNC-116::GFP::TOMM-7), thereby bypassing
the requirement of RIC-7 for the transport of these organelles
(Rawson et al., 2014). We found a strong rescue of the axonal
degeneration defect in ric-7 animals expressing this construct
(Figure 5B), supporting a specific, cell-autonomous role for mito-
chondria in regulating the rate of axonal degeneration in PLM.
DISCUSSION
Model organisms have been instrumental in our understanding
of the molecular mechanisms behind axonal degeneration and
the active Wallerian degeneration pathway (Coleman and
Freeman, 2010). We have characterized axonal degeneration in
C. elegans, investigated the molecules involved in this process,
and examined whether the Wallerian degeneration pathway is
functionally conserved in this species. We show that following
laser-induced axotomy, C. elegans PLM mechanosensory and
DD motor axons degenerate with morphological similarity to
Wallerian degeneration, although there is no delay between
fragmentation and clearance of the transected axon as in other
organisms. Surprisingly, we also demonstrate thatWldS expres-
sion does not delay axonal degeneration in different C. elegans
neurons. We show that this lack of effect is not due to a lack of
function, as the same transgene can protect against necrotic
neurodegeneration caused bymec-4(d). In mammalian systems,
WLDS has been shown to increase mitochondrial flux and cal-
cium buffering capacities (Avery et al., 2012), whereas the
mec-4(d) mutation causes calcium channels to be constitutively
open, leading to necrosis (Bianchi et al., 2004; Driscoll and Chal-
fie, 1991). Therefore, WLDS could protect againstmec-4(d) neu-
rodegeneration by enhancing the capacity of mitochondria to
buffer the influx of calcium. Also unexpectedly, but consistent
with the inability ofWLDS to protect against axonal degeneration,
we found that the orthologs of dNmnat/Nmnat1, dsarm/Sarm1,
Wallenda/Dlk1, and Highwire/Phr, which are involved in the
conserved Wallerian degeneration program in Drosophila andeports 14, 1673–1683, February 23, 2016 ª2016 The Authors 1679
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Figure 5. Mitochondria Are Largely Absent from the PLM Axon in
ric-7 Mutant Animals and Are Important for Delaying Axonal
Degeneration
(A) Mitochondria visualized through expression of TOMM-20::mRFP at the L1-
stage in wild-type (top panels) and ric-7(nu447) (bottom panels) animals,
highlighting the lack of mitochondria within the axons of PLM in ric-7mutants.
(B) PLM axons of L4 ric-7(nu447) animals show a significant increase in
degeneration and clearance compared to wild-type L4 animals after 24 hr,
closely resembling the degree of degeneration and clearance in wild-type L1
animals. This defect can be rescuedwith cell-autonomous expression ofUNC-
116::GFP::TOMM-7 to restore mitochondrial localization in the axon. The area
of each circle represents the proportion of data points that fall into that cate-
gory; n value indicated on top of each bubble graph. *p < 0.05, ***p < 0.0005 as
determined by a Kruskal-Wallis and Dunn’s or a Mann-Whitney test.vertebrates (Fang et al., 2012; Gilley and Coleman, 2010; Itoh
et al., 2009; Osterloh et al., 2012; Xiong and Collins, 2012; Xiong
et al., 2012) had no significant role in axonal degeneration
following laser axotomy inC. elegansmechanosensory neurons.
In contrast, we found a conserved function in C. elegans for
CED-1, CED-6, CED-2, CED-5, CED-12, and CED-10, all mole-
cules that are known to be involved in axonal clearance in1680 Cell Reports 14, 1673–1683, February 23, 2016 ª2016 The Authdifferent species. Their effects appear to be restricted to the L1
stage during which the rate of axonal degeneration/clearance
is extremely fast, with no effect detected at the L4 stage where
the PLM axonal degenerative phenotype proceeds very slowly.
Notably, tissue-specific rescue experiments with CED-1 and
CED-6, and analysis of EM serial sections, demonstrated that
the hypodermis is responsible for the clearance of the severed
PLM axon. During apoptosis, the normally internally localized
PS is externalized to the outer leaflet and serves as an ‘‘eat
me’’ signal for engulfing phagocytes. The ABC transporter,
CED-7, has previously been shown to promote the generation
of PS-containing extracellular vesicles (Mapes et al., 2012). Inter-
estingly, our data reveal a function for CED-7 in promoting
axonal degeneration/clearance in L1 animals, whereas it ap-
pears to switch to a suppressivemode in L4 animals (Figure S3B).
This resembles the function of CED-7 in apoptotic clearance. In
apoptosis, CED-7 has two functions, the first involving early pro-
duction of lipid-containing vesicles that promote clearance, and
the second involving later removal of lipids from the apoptotic
cell. In axonal degeneration, CED-7 may be acting early in L1
to promote the secretion of lipids from the PLM axon, which
function as ‘‘eat me’’ signals leading to clearance. Conversely,
in the L4 stage, during which degeneration proceeds over a
longer timeline, the main function of CED-7 may switch to
removal of lipids, thereby preventing clearance. Therefore, loss
of CED-7 at the L4 stage leads to an accumulation of lipids on
the axon, causing increased clearance. How exactly CED-7
can switch between these two modes and how this is regulated
are currently unknown. A possible involvement of lipids is sup-
ported by our results with NRF-5, a lipid-binding protein that
functions with CED-7 tomediate PS transfer from apoptotic cells
to phagocytes, which also affects the axonal degenerative
phenotype. However, our results from mutants in the tat-1,
scrm-1, ttr-52, psr-1, and ina-1 genes, in which the axonal
degenerative phenotype is not altered, could indicate either
that CED-7 also has a function that is independent of PS, or
that PS is produced and recognized by other molecules in the
context of degeneration. Overall, our results suggest conserva-
tion of the molecular machinery involved in axonal clearance
and raise the possibility that CED-7 and NRF-5 have an impor-
tant role in this process in species other than nematodes.
In C. elegans, a severed axon can present a new growth cone
at the end of the proximal fragment within 6 hr of surgery (Wu
et al., 2007), and this regrowing axon can reconnect to its sepa-
rated distal fragment to restore the original axon tract, in a pro-
cess known as axonal fusion (Ghosh-Roy et al., 2010; Neumann
et al., 2011, 2015; Wu et al., 2007). Remarkably, we have shown
that some of the same molecules involved in axonal degenera-
tion, such as CED-7, NRF-5, and CED-6, also regulate axonal
fusion in L4 animals (Neumann et al., 2015). This suggests that,
in a number of C. elegans neurons, axotomy triggers a tug-of-
war between the axonal repair event occurring by way of axonal
fusion and degeneration/clearance of the distal axon fragment
mediated by the surrounding hypodermis (Hilliard, 2009). For
example, the nuclear receptor FAX-1 has been shown to simul-
taneously increase axonal regeneration and decrease degener-
ation in C. elegans AVK interneurons (Yaniv et al., 2012). In
contrast, the presence of the distal fragment is inhibitory forors
regeneration and neuroplasticity in vertebrates (Martin et al.,
2010). Delaying axonal degeneration through WldS expression
has been shown to substantially delay the locomotory recovery
of mice following partial spinal cord lesions from 6 to 16 days
(Zhang et al., 1998). This may explain why vertebrates have
evolved to rapidly clear the inhibitory axonal fragments through
an active degeneration pathway. The evolutionary pressure
dictating why vertebrates have reduced regeneration in the pres-
ence of distal fragments, as well as in the CNS, is still a point of
speculation. However, although it is presumably advantageous
for mammals to actively promote axonal degeneration in order
to undergo regeneration, there seems to be no such benefit for
C. elegans. Even so, the need and mechanisms to clear axons
once they have degenerated appear widely conserved.EXPERIMENTAL PROCEDURES
Strains
Animals were maintained at room temperature (22C) on nematode growth
medium (NGM) plates seeded with Escherichia coli OP50 according to
standardmethods. The following strains were obtained from theCaenorhabdi-
tis Genetic Center (CGC): RB1085 [tir-1(ok1052)], CB3203 [ced-1(e1735)],
MT8347 [ced-3(n2452)], MT2547 [ced-4(n1162)], MT4433 [ced-6(n1813)],
MT9258 [ced-7(n2690)], VC537 [psr-1(ok714)], NG144 [ina-1(gm144)],
CB3257 [ced-2(e1752)], MT4434 [ced-5(n1812)], ZB547 [ced-12(bz187)],
MT9958 [ced-10(n3246)], CB1066 [mec-1(e1066)], JT513 [nrf-5(sa513)],
CZ1251 [rpm-1(ju41)], CZ5730 [dlk-1(ju476)], KP2048 [ric-7(nu447)], NY2037
[ynIs37(Pflp-13::GFP)], and the National Bioresource Project (NBRP): FX0805
[scrm-1(tm805)], FX3036 [tir-1(tm3036)], and FX3117 [tat-1(tm3117)].
The following transgenes were generated by microinjection (concentrations
used for the microinjection mix are indicated in brackets; all injection mixes
had a total concentration of 100 ng/ml and empty pSM plasmid was used as a
filler): vdEx289/vdEx290/vdEx291 [Pmec-4::WldS (5 ng/ml); Podr-1::DsRed
(30 ng/ml)], vdEx295/vdEx296/vdEx297 [Pmec-4::WldS (10ng/ml); Podr-1::DsRed
(30 ng/ml)], vdEx298/vdEx299 [Pmec-4::WldS (20 ng/ml); Podr-1::DsRed
(30 ng/ml)], vdEx429/vdEx430/vdEx431 [Pflp-13::WldS (5 ng/ml); Podr-1::
DsRed (30 ng/ml)], vdEx717/vdEx718/vdEx720 [Pflp-13::WldS (10 ng/ml); Podr-
1::DsRed (30 ng/ml)], vdEx722/vdEx723/vdEx724 [Pflp-13::WldS (20 ng/ml);
Podr-1::DsRed (10 ng/ml)], vdEx294 [Pmec-4::WldS::mCherry (5 ng/ml); Podr-1::
DsRed (30 ng/ml)], vdEx422 [Pmec-4::nmat-1 (5 ng/ml); Podr-1::DsRed
(30 ng/ml)]; vdEx424 [Pmec-4::nmat-1 (20 ng/ml); Podr-1::DsRed (30 ng/ml)],
vdEx426/vdEx427/vdEx428 [Pmec-4::nmat-2 (5 ng/ml); Podr-1::DsRed
(30 ng/ml)], vdEx437/vdEx438/vdEx439 [Pmec-4::nmat-2 (10 ng/ml); Podr-
1::DsRed (30 ng/ml)], vdEx502 [Pmec-4::nmat-2 (20 ng/ml); Podr-1::DsRed
(30 ng/ml)], vdEx1058 [Pdpy-7::ced-1::mRFP (1 ng/ml); Podr-1::DsRed
(30 ng/ml)], vdEx1025/vdEx1027 [Pdpy-7::ced-1::mRFP (5 ng/ml); Podr-1::DsRed
(30 ng/ml)], vdEx895 [Pmec-4::mRFP::ced-6 (5 ng/ml); Podr-1::DsRed (30 ng/ml)],
vdEx1059 [Pdpy-7::mRFP::ced-6 (1 ng/ml); Podr-1::DsRed (30 ng/ml)], vdEx239
[Pmec-4::mCherry::rab-3 (0.5 ng/ml); Podr-1::DsRed (30 ng/ml)], vdIs13[Pmec-
4::tomm-20::mRFP (0.5 ng/ml); Punc-22::GFP (25 ng/ml)], vdEx919[Pmec-
4::myr::mCherry (5 ng/ml); Podr-1::DsRed (60 ng/ml)]; vdEx1124[Pmec-4::unc-
116::GFP::tomm-7 (10 ng/ml); Podr-1::DsRed (60 ng/ml)]. smIs65[Phsp::sAnxV::
mRFP] was used for the Annexin experiments.
Molecular Biology
Molecular biology was performed using standard techniques (Sambrook et al.,
1989). All primers were sourced from GeneWorks. WldS was amplified from
theWldS plasmid (a gift fromMichael Coleman, Babraham Institute, University
of Cambridge) and cloned into pSM plasmids containing either Pmec-4
(Pmec-4::WldS), Pmec-4::mCherry (Pmec-4::mCherry::WldS), or Pflp-13
(Pflp-13::WldS) using 50-TCAGTGGGATCCATGGAGGAGCTGAGCGCTG-30
paired with either 50-TACGGAATTCTCACAGAGTGGAATGGTTGTGC-30 (for
cloning into the Pmec-4 plasmid using BamHI and EcoRI sites) or 50-
TCAGTGGGATCCGCCAGAGTGGAATGGTTGTGCT-30 (for cloning into theCell RPmec-4::mCherry plasmid using BamHI). Genomic sequences of nmat-1
and nmat-2 were each cloned into pSM plasmids containing the mec-4
promoter using the 50-TCAGTGGCTAGCCTATGGGGACCGAAAAAGTTG-30
and 50-TCAGTGACCGGTGCTCATTCGTAGAGTCTATGAT-30 or the 50-TCA
GTGGCTAGCACGATGAAACGAGTCGCTCT-30 and 50-GGGGGACCGGTAT
TAAATTTTCTGATACAGATTATTCT-30 primers, respectively, which include
NheI and AgeI sites and genomic DNA frommixed-stage animals as a template
(whole-animal lysates performed as previously described [Wicks et al., 2001]).
The dpy-7 promoter (Gilleard et al., 1997) was amplified from genomic
C. elegans DNA using 50-AAAAAAGGATCCTTATCTGGAACAAAATGTAAG-30
and 50-CGACGCCTGCCTTGAAACACTAC-30 which include BamHI and
HindIII sites for insertion into the pSM plasmid. pSM plasmids carrying
Pmec-4::ced-1::mRFP and Pmec-4::mRFP::ced-6 were used to replace the
mec-4 promoter with the dpy-7 promoter.
The Pmec-4::UNC-116::GFP::TOMM-7 plasmid was built as follows: UNC-
116::GFP::TOMM-7 was amplified from the pRR125 plasmid (a gift from
Erik Jorgensen, University of Utah) using primers 50-CGCGGATCCC
AAAAAAGCAGGCTGCATGG-30 and 50- ATTGGGCCCGCCAAGCGAGGA
CAATTCTC-30 and cloned into Pmec-4 pSM using BamHI and ApaI restriction
sites.
To build Pmec-4::MYR::mCherry, the insert MYR::mCherry (from the
plasmid pNV myr::mCherry) was cloned into pSM Pmec-4::GFP using MscI
and EcoRI restriction sites (replacing GFP with MYR::mCherry).
Microscopy
Fluorescence microscopy was performed using an upright Zeiss AxioImager
Z1 equipped with epifluorescence, differential interference contrast (DIC),
and a Cool SNAP HQ2 camera (Photometrics) or an AxioCam MRm camera
(Carl Zeiss). Images were acquired and processed using either Metamorph
or AxioVision Release 4.8 software. Additional processing was completed us-
ing ImageJ 64. Worms were anesthetized with 0.01%–0.05% tetramisole on
4% agar pads.
Mitochondria were visualized using the vdIs13(Pmec-4::tomm-20::mRFP;
Punc-122::GFP) transgene and a LSM710META confocal microscope, equip-
ped with GaAsP detectors and Zen 2012 software. Green cytoplasmic fluores-
cencewas visualizedwith a 488-nm laser (0.15%power, with a gain of 650 and
83 averaging), and red fluorescence was visualized with a 561-nm laser (1.5%
power, with a gain of 600 and 83). Animals were analyzed at the L1 and L4
stages as indicated.
Laser Axotomy
A MicroPoint 337 UV laser mounted onto an upright Zeiss AxioImager A1
equipped for fluorescence and DICmicroscopywas used to perform individual
axon transections. Animals were operated at the L1 (6 hr after hatching) or L4
stage, while anesthetized with 0.01%–0.05% tetramisole on 4%agar pads un-
less otherwise specified. The surgery was performed on the axon of the PLM
neuron approximately 50 mm anterior to the cell body in the case of L4 animals
and approximately 10 mm anterior to the cell body in L1 animals. In the case of
the DD motor neurons, axotomies were performed approximately halfway
across the commissure for DD3 and DD5, and cell bodies were ablated
post-axotomy to prevent regeneration that would complicate visualization of
the distal fragments. Animals were recovered on NGM plates seeded with
E. coli and observed at the single time point indicated. For the Annexin exper-
iments, L1 animals receiving the heat shock (wild-type and Phsp::sAnxV) were
placed at 30C for 30 min, 4 hr prior to axotomy.
Electron Microscopy
72 hr post-axotomy of PLM in L4 animals, fluorescence imaging was used to
determine the axonal degeneration phenotype of the PLM distal axonal frag-
ment. Fixation of single animals was achieved by transection of the animal in
the middle of the anterior half of the body in buffered aldehydes, followed by
incubation in osmium tetroxide, uranyl acetate, and positioning in groups in
agar cubes prior to embedding in Epon resin (Hall, 1995). Serial thin sections
were collected onto plastic-coated slot grids (Pioloform) frommultiple animals
at once and post-stained with uranyl acetate. Digital Transmission EM images
were collected using iTEM software on an Olympus Morada camera mounted
on a Philips CM10 electron microscope.eports 14, 1673–1683, February 23, 2016 ª2016 The Authors 1681
Data Analysis
Degeneration data were gathered by qualitative measurements. Degeneration
of each axotomized PLM was classified on a scale of 1 (complete clearance
of the distal fragment) to 5 (no degeneration) (Figure 1A). Data were analyzed
using the Mann-Whitney test for single comparisons and a Kruskal-
Wallis and Dunn’s post hoc test for multiple comparisons. In the case of the
mec-4(d) phenotypic data, proportions were compared by calculating
z-ratios for the significances of the differences between the independent
proportions.
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